COGT

COGENT BIOSCIENCES INC

COGT·19240Q201·US·Common Stock·Healthcare - Biotechnology-Activist

COGT (COGENT BIOSCIENCES INC) is held by 145 institutional investors as of Q1 2026. Largest holders: FMR LLC ($890M), BlackRock, Inc. ($617.6M), VANGUARD PORTFOLIO MANAGEMENT LLC ($282.3M). Net institutional sentiment: Mixed.

145
Holders
(12 Elite)
$4.8B
Total Value
65% (153)
Consensus
100 buying - 53 selling
13F: Insider & Congress:
COGTSmart Money Verdict
View all
Held by 145 funds
12 elite
Who's Trading
ActivistDMDeerfield Mgmt, L.P.5.3%May 14, 2026
InsiderFLFairmount Funds Management LLCSell $242.6MMar 31, 2026
ActivistFAFairmount Funds Management LLC8.6%Mar 31, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
ActivistKYKynam Capital Management, LP4.3%Feb 17, 2026
ActivistCOCommodore Capital LP1.8%Feb 17, 2026
InsiderFLFairmount Funds Management LLCSell $127.4MJan 22, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.5%Jan 21, 2026
InsiderRERobinson John EdwardSell $3.5MDec 26, 2025
InsiderSJSachs JessicaSell $3.2MDec 26, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
23.1M(+0.1%)$890M0.0%+285.93%
32
Increased
16M(+23.7%)$617.6M0.0%+106.58%
38
New
7.3M$282.3M0.0%+4.38%
43
New
6.9M$265.4M0.0%+4.38%
43
Increased
6M(+31.5%)$229.6M0.1%+80.67%
47
Increased
5.7M(+14.6%)$218M0.0%+194.10%
35
Decreased
5.5M(-28.1%)$210.1M2.1%+46.02%
0
Increased
4.4M(+160.0%)$170.7M0.0%+45.11%
49
Increased
3.7M(+5.3%)$142.4M0.0%+181.97%
32
Increased
3.6M(+31.9%)$137.7M0.0%+14.56%
39
Increased
3.2M(+25.3%)$123.7M0.0%+6.84%
37
Increased
2.4M(+314.8%)$93.5M0.0%+16.37%
48
Increased
2.3M(+91.0%)$86.6M0.2%+8.06%
56
Decreased
1.9M(-16.9%)$71.9M0.0%+87.20%
0
Increased
1.8M(+1499.3%)$68.8M0.1%+5.00%
48
Increased
1.7M(+19.2%)$66M0.0%+149.91%
35
Decreased
1.6M(-3.6%)$61.6M0.1%+37.71%
0
Increased
1.5M(+17.0%)$58.4M0.3%+87.88%
41
Increased
1.5M(+84.4%)$58.1M0.2%+45.27%
55
Increased
1.4M(+70.5%)$54.3M0.1%+89.21%
44

Showing 1-20 of 157

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used